154 related articles for article (PubMed ID: 24045233)
1. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
Underwood CR; Knudsen LB; Garibay PW; Peters GH; Reedtz-Runge S
Peptides; 2013 Nov; 49():100-8. PubMed ID: 24045233
[TBL] [Abstract][Full Text] [Related]
2. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
4. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
[TBL] [Abstract][Full Text] [Related]
5. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glucagon-like peptide-1 receptor-binding determinants.
Xiao Q; Jeng W; Wheeler MB
J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
[TBL] [Abstract][Full Text] [Related]
7. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
Wang H; Hu W; Liu D; Wüthrich K
FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
[TBL] [Abstract][Full Text] [Related]
8. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
Al-Zamel N; Al-Sabah S; Luqmani Y; Adi L; Chacko S; Schneider TD; Krasel C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330984
[TBL] [Abstract][Full Text] [Related]
9. Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket.
Mann RJ; Al-Sabah S; de Maturana RL; Sinfield JK; Donnelly D
Peptides; 2010 Dec; 31(12):2289-93. PubMed ID: 20869417
[TBL] [Abstract][Full Text] [Related]
10. Peptide binding at the GLP-1 receptor.
Mann R; Nasr N; Hadden D; Sinfield J; Abidi F; Al-Sabah S; de Maturana RL; Treece-Birch J; Willshaw A; Donnelly D
Biochem Soc Trans; 2007 Aug; 35(Pt 4):713-6. PubMed ID: 17635131
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
Thompson A; Kanamarlapudi V
Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors.
Jüppner H
Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):371-8. PubMed ID: 8076140
[TBL] [Abstract][Full Text] [Related]
13. Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function.
Yeung CM; Mojsov S; Mok PY; Chow BK
Endocrinology; 2002 Dec; 143(12):4646-54. PubMed ID: 12446592
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
[TBL] [Abstract][Full Text] [Related]
15. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
16. A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
Beinborn M; Worrall CI; McBride EW; Kopin AS
Regul Pept; 2005 Aug; 130(1-2):1-6. PubMed ID: 15975668
[TBL] [Abstract][Full Text] [Related]
17. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
[TBL] [Abstract][Full Text] [Related]
18. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
[TBL] [Abstract][Full Text] [Related]
19. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
20. Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity.
Vázquez P; Roncero I; Blázquez E; Alvarez E
J Endocrinol; 2005 Apr; 185(1):35-44. PubMed ID: 15817825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
